Caffeine Sodium Benzoate from Japan
Double salt combining caffeine with sodium benzoate, used in parenteral migraine treatments. Classified under HTS 2939.30.00.00 as a caffeine salt per Chapter Note 4(C)(1). Supplied as sterile powder for IV solutions.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6215%Patented pharmaceutical articles that are the product of Japan, of a European Union member country, of South Korea, of Switzerland, or of Liechtenstein as provided for in subdivisions (c) and (f) of U.S. note 40 to this subchapter
9903.05.860%Articles provided for in subdivision (b) of U.S. note 52 to this subchapter
Import Tips
• Provide certificates for both caffeine and benzoate components; Sterility testing required for injectable use; Benzoate content declaration prevents misclassification